Head-To-Head Analysis: Exponent (EXPO) vs. Huron Consulting Group (HURN)

Exponent (NASDAQ: EXPO) and Huron Consulting Group (NASDAQ:HURN) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, institutional ownership, valuation, earnings and analyst recommendations.

Profitability

This table compares Exponent and Huron Consulting Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Exponent 16.46% 17.21% 11.99%
Huron Consulting Group -17.09% 7.50% 3.83%

Dividends

Exponent pays an annual dividend of $0.84 per share and has a dividend yield of 1.1%. Huron Consulting Group does not pay a dividend. Exponent pays out 41.0% of its earnings in the form of a dividend.

Valuation & Earnings

This table compares Exponent and Huron Consulting Group’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Exponent $315.08 million 6.23 $47.48 million $2.05 37.10
Huron Consulting Group $797.98 million 1.11 $37.61 million ($6.38) -6.27

Exponent has higher revenue, but lower earnings than Huron Consulting Group. Huron Consulting Group is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.0% of Exponent shares are owned by institutional investors. Comparatively, 87.9% of Huron Consulting Group shares are owned by institutional investors. 2.8% of Exponent shares are owned by company insiders. Comparatively, 2.7% of Huron Consulting Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current recommendations for Exponent and Huron Consulting Group, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exponent 0 1 1 0 2.50
Huron Consulting Group 0 2 3 0 2.60

Exponent currently has a consensus target price of $79.50, indicating a potential upside of 4.54%. Huron Consulting Group has a consensus target price of $48.00, indicating a potential upside of 20.00%. Given Huron Consulting Group’s stronger consensus rating and higher probable upside, analysts plainly believe Huron Consulting Group is more favorable than Exponent.

Risk & Volatility

Exponent has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Huron Consulting Group has a beta of 0.06, indicating that its share price is 94% less volatile than the S&P 500.

Summary

Exponent beats Huron Consulting Group on 11 of the 16 factors compared between the two stocks.

Exponent Company Profile

Exponent, Inc. (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences and vehicle analysis services. Its Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences, and health sciences. Exponent serves clients in automotive, government, health, insurance, manufacturing and technology, among others.

Huron Consulting Group Company Profile

Huron Consulting Group Inc. is a global professional services firm. The Company offers solutions in operations, advisory services, technology and analytics for healthcare, higher education, life sciences and commercial sectors. The Company’s segments include Healthcare, Education and Life Sciences, and Business Advisory. Its Healthcare segment provides advisory services, from strategy setting through implementation, in the areas of organizational and resource alignment, clinical transformation, financial and operational performance, patient and caregiver engagement, and technology implementation and optimization. Its Education and Life Sciences segment provides management consulting and technology solutions to the higher education and academic medical centers, pharmaceutical and medical device, biotechnology and research industries. The Business Advisory segment’s primary service lines include Enterprise Solutions and Analytics, and Business Advisory.

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply